Discovery of dihydropyrazino-benzimidazole derivatives as metabotropic glutamate receptor-2 (mGluR2) positive allosteric modulators (PAMs)

被引：5

作者：

Szabo, Gyorgy ^{[1
]}

Kolok, Sandor ^{[1
]}

Orgovan, Zoltan ^{[2
]}

Vastag, Monika ^{[1
]}

Beni, Zoltan ^{[1
]}

Koti, Janos ^{[1
]}

Saghy, Katalin ^{[1
]}

Levay, Gyorgy I. ^{[1
]}

Greiner, Istvan ^{[1
]}

Keseru, Gyorgy M. ^{[2
]}

机构：

[1] Gedeon Richter Plc, 19-21 Gyomroi Ut, H-1103 Budapest, Hungary

[2] Hungarian Acad Sci, Res Ctr Nat Sci, Med Chem Res Grp, 2 Magyar Tudosok Korutja, H-1117 Budapest, Hungary

来源：

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2020年 / 186卷

关键词：

mGlu(2) receptor; Positive allosteric modulator; Scaffold hopping; Dihydropyrazino-benzimidazoles; Pharmacophore based optimization; SCHIZOPHRENIA; PHARMACOPHORE; PHARMACOLOGY; AGONIST;

D O I：

10.1016/j.ejmech.2019.111881

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A scaffold hopping strategy converted the known 1-[(1-methyl-1H-imidazol-2-yl)methyl]-4-phenylpiperidine core (1 and 2) by cyclization to a fused [6 + 5+6] membered heterocyclic mGluR2 PAM scaffold. Pharmacophore guided structure-activity relationship (SAR) studies resulted in a series of potent and metabolically stable mGluR2 PAMs. A representative optimized compound (95) having the most balanced profile, demonstrated efficacy in the PCP-induced hyper-locomotion model in mice that revealed the new chemotype being a promising PAM lead targeting mGluR2 receptors and providing support for further translational studies. (C) 2019 Elsevier Masson SAS. All rights reserved.

引用

页数：17

共 50 条

[31] Benzazoles as allosteric potentiators of metabotropic glutamate receptor 2 animal model (mGluR2): Efficacy in an for schizophrenia
Govek, SP
Bonnefous, C
Hutchinson, JH
Kamenecka, T
McQuiston, J
Pracitto, R
Zhao, LX
Gardner, MF
James, JK
Daggett, LP
Rowe, BA
Schaffhauser, H
Bristow, LJ
Campbell, UC
Rodriguez, DE
Vernier, JM
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (18) : 4068 - 4072
[32] Centrally active positive allosteric modulators (PAMs) of metabotropic glutamate receptor 5 (mGluR5) for traumatic brain injury (TBI)
He, Xinhua
Hanscom, Marie
Stoica, Bogdan
MacKerell, Alexander D., Jr.
Fedan, Alan I.
Xue, Fengtian
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 246
[33] Discovery, SAR and antiparkinsonian effect of novel positive allosteric modulators (PAMs) and ago-potentiators of metabotropic glutamate receptor subtype 4 (mGluR4)
Lindsley, Craig W.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
[34] Synthesis and Evaluation of a Series of Heterobiarylamides That Are Centrally Penetrant Metabotropic Glutamate Receptor 4 (mGluR4) Positive Allosteric Modulators (PAMs)
Engers, Darren W.
Niswender, Colleen M.
Weaver, C. David
Jadhav, Satyawan
Menon, Usha N.
Zamorano, Rocio
Conn, P. Jeffrey
Lindsley, Craig W.
Hopkins, Corey R.
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (14) : 4115 - 4118
[35] A highly selective agonist for the metabotropic glutamate receptor mGluR2
Nielsen, Simon D.
Fulco, Marica
Serpi, Michaela
Nielsen, Birgitte
Hansen, Maria B.
Hansen, Kasper L.
Thomsen, Christian
Brodbeck, Robb
Brauner-Osborne, Hans
Pellicciari, Roberto
Norrby, Per-Ola
Greenwood, Jeremy R.
Clausen, Rasmus P.
MEDCHEMCOMM, 2011, 2 (11) : 1120 - 1124
[36] 2-substituted benzimidazoles as low fold-shift positive allosteric modulators at the metabotropic glutamate receptor-2
Topiwala, U.
Jimenez, N.
Chen, H.
Uberti, M.
Jones, K.
Marzabadi, M.
Labelle, M.
Doller, D.
NEUROPHARMACOLOGY, 2008, 55 (04) : 627 - 628
[37] Positive Allosteric Modulators for mGluR2 Receptors: A Medicinal Chemistry Perspective
Szabo, Gyoergy
Keseru, Gyoergy Miklos
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2014, 14 (15) : 1771 - 1788
[38] Chemical Switch of a Metabotropic Glutamate Receptor 2 Silent Allosteric Modulator into Dual Metabotropic Glutamate Receptor 2/3 Negative/Positive Allosteric Modulators
Schann, Stephan
Mayer, Stanislas
Franchet, Christel
Frauli, Melanie
Steinberg, Edith
Thomas, Mireille
Baron, Luc
Neuville, Pascal
JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (24) : 8775 - 8779
[39] Characterization of the Clinical Effect of a Positive Allosteric Modulator of the Metabotropic Glutamate Receptor-2
De Boer, Peter
Sinha, Vikash
Hoeben, Eva
Anghelescu, Ion-George
Kezic, Iva
Daly, Ella
Ceusters, Marc
De Smedt, Heidi
Van Nueten, Luc
Kent, Justine M.
BIOLOGICAL PSYCHIATRY, 2013, 73 (09) : 319S - 319S
[40] Pharmacological characterisation of positive allosteric modulators acting on the metabotropic glutamate receptor 2
Bennett, K. A.
Weaver, A.
Marshall, F.
Langmead, C. J.
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S4 - S5

← 1 2 3 4 5 →